Technology News and Research

RSS

Mucosis collaborates with PATH to pursue use of Mimopath technology in diarrhea vaccines

Dutch biotechnology company Mucosis B.V. announced today that it has entered into a collaboration agreement with the global health nonprofit organization PATH to pursue the use of the company's Mimopath technology in oral vaccines to prevent and treat severe diarrhea.

28 Sep 2010

Tel Aviv researchers develop innovative software to analyze and manipulate diseased cells

About ten years ago, the discovery of microRNAs ― tiny cellular molecules that regulate our genetic code ― unlocked a world of scientific possibilities, including a deeper understanding of human disease. One new analytical technology is "deep sequencing," which gives scientists the ability to discover invaluable information about human diseases at a genetic level.

28 Sep 2010

HealthWyse secures patent for Remote Personnel Tracking program to prevent Medicare fraud

HealthWyse, a leading provider of home health and hospice agency automation software, announced today that it has secured a patent for its Remote Personnel Tracking program to help homecare agencies keep track of their employees and prevent Medicare fraud. HealthWyse will showcase its Remote Personnel Tracking Program at the National Association for Home Care and Hospice (NAHC) 29th Annual Meeting & Exposition, held October 2 - 6 in Dallas, Texas.

28 Sep 2010

Study investigates link between cough and reflux events using sound recording device

Coughing episodes are closely related to gastroesophageal reflux symptoms in patients who experience chronic cough, irrespective of other diagnoses, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

28 Sep 2010

Vivakor to structure acquisition partners to commercialize VivaSlices and VivaSight technologies

Vivakor, Inc. today announced that due to the increased interest in the Company's technologies, the Company is looking to structure acquisition partners for its technologies which will allow for the investment needed to fully commercialize VivaSlices and VivaSight technologies.

28 Sep 2010

NPL, Orla receives fund to improve detection methods for TB

Two UK companies have been awarded joint funding for a research project that could see significant advances in the quest to aid detection and eradication of Tuberculosis (TB), across the world.

28 Sep 2010

Viridis BioPharma receives approval to manufacture, market NIMBUS antimicrobial technology in India

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that its proprietary NIMBUS antimicrobial technology has been approved for manufacture, marketing and sale in India. Viridis BioPharma, an India-based manufacturer and marketer of medical devices, received approval by the Food and Drug Administration of India to manufacture and market gauze wound dressings that incorporate NIMBUS antimicrobial technology.

28 Sep 2010

Oxygen Biotherapeutics to showcase DERMACYTE oxygen-rich skin care products at Spa & Resort expo

Oxygen Biotherapeutics, Inc. will showcase for the first time its DERMACYTE oxygen-rich skin care products at the Spa & Resort/Medical Aesthetics Spa Conference and Expo at the Jacob K. Javits Convention Center in New York City starting tomorrow.

28 Sep 2010

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

"The best way to help the millions of hungry people in countries that receive food aid get rid of their corrupt and incompetent rulers - and to ensure that their children will never go hungry in future — is to starve them now. That will turn them into raging, unstoppable anti-government regime changers," writes Nation Media Group Executive Editor Charles Onyango-Obbo in an East African opinion piece.

28 Sep 2010

C-CCNE receives grant to improve cancer treatment using nanotechnology

The National Cancer Institute has awarded a five-year, $13.6 million grant to the University of North Carolina at Chapel Hill's Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) based at the UNC Lineberger Comprehensive Cancer Center, for research to improve the diagnosis and treatment of cancer through applying/using advances in nanotechnology.

28 Sep 2010

OpGen completes Series B equity financing

OpGen, Inc., a commercial phase genomics company, today announced the successful completion of a $17 million Series B equity financing.

28 Sep 2010

Acclarent's new technologies improve visualization during sinus surgery

Acclarent, Inc., a leader in minimally-invasive sinus surgery, today announced the introduction of two new technologies designed to improve visualization during sinus surgery The Acclarent Cyclops Multi-Angle Endoscope and the Relieva Luma Sentry Sinus Illumination System.

28 Sep 2010

HHS pumps up rhetoric but eases rules on health insurance for kids

Politico reports that the administration "is taking health insurers to task again, this time for choosing to no longer sell plans intended to cover sick children." Insurers "have said in recent weeks that they would stop selling 'child only' insurance plans because the overhaul requires them to accept all applicants, even if they apply for coverage at the last minute before treatment." In a letter to industry groups, Health and Human Services Secretary Kathleen Sebelius highlighted the "plight of millions of parents who desperately want to provide health coverage and critical treatments" in the face of insurer decisions.

28 Sep 2010

IAVI investigators awarded grant to examine antibodies that neutralize HIV virus

A team of investigators headed by International AIDS Vaccine Initiative Investigator Pascal Poignard has been awarded a major grant from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health to investigate the biological mechanisms underlying the generation of broadly neutralizing antibodies by HIV positive individuals.

28 Sep 2010

Government health IT market poised to grow dramatically

The Washington Post reports on the growing field of government health IT jobs.

28 Sep 2010

Genomics obtains worldwide rights to The Garvan Institute of Medical Research's methylation DNA biomarkers

Clinical Genomics Pty. Ltd (Sydney, Australia) and The Garvan Institute of Medical Research (Sydney, Australia) today announced that they have entered into a license agreement in relation to novel biomarkers discovered by scientists at the Garvan Institute. Under the terms of the agreement, Clinical Genomics obtains worldwide exclusive rights to the Garvan's proprietary cancer associated methylation DNA biomarkers for the diagnosis and or treatment of colorectal cancer.

28 Sep 2010

DecImmune Therapeutics receives funds to improve ischemia reperfusion injury outcomes

DecImmune Therapeutics announced today that it has received a $1 million equity investment from Astellas Venture Management and has additionally been awarded $2.2 million in Phase II SBIR funding from the National Institutes of Health.

28 Sep 2010

Guided Therapeutics files PMA for LightTouch Cervical Scanner

Guided Therapeutics, Inc. announced that it filed its completed premarket approval application (PMA) for the LightTouch Cervical Scanner with the U.S. Food and Drug Administration (FDA) for patients at risk for cervical cancer.

28 Sep 2010

KeyVive provides Simplatype mHealth SMS technology to improve healthcare

KeyVive, Inc., a healthcare technology company that uses social media and self management tools to help individuals with chronic illnesses, is dialing up a ground-breaking, HIPAA compliant mHealth technology for people not only affected by diabetes, but also with other diseases.

28 Sep 2010

ATSC to provide software development services for NCI

ATS Corporation, a leading information technology company that delivers innovative technology solutions to government and commercial organizations, today announced that it has been awarded a new contract totaling $13.3 million over a five-year term with the National Cancer Institute.

28 Sep 2010

Technology News and Research

Mucosis collaborates with PATH to pursue use of Mimopath technology in diarrhea vaccines

Tel Aviv researchers develop innovative software to analyze and manipulate diseased cells

HealthWyse secures patent for Remote Personnel Tracking program to prevent Medicare fraud

Study investigates link between cough and reflux events using sound recording device

Vivakor to structure acquisition partners to commercialize VivaSlices and VivaSight technologies

NPL, Orla receives fund to improve detection methods for TB

Viridis BioPharma receives approval to manufacture, market NIMBUS antimicrobial technology in India

Oxygen Biotherapeutics to showcase DERMACYTE oxygen-rich skin care products at Spa & Resort expo

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

C-CCNE receives grant to improve cancer treatment using nanotechnology

OpGen completes Series B equity financing

Acclarent's new technologies improve visualization during sinus surgery

HHS pumps up rhetoric but eases rules on health insurance for kids

IAVI investigators awarded grant to examine antibodies that neutralize HIV virus

Government health IT market poised to grow dramatically

Genomics obtains worldwide rights to The Garvan Institute of Medical Research's methylation DNA biomarkers

DecImmune Therapeutics receives funds to improve ischemia reperfusion injury outcomes

Guided Therapeutics files PMA for LightTouch Cervical Scanner

KeyVive provides Simplatype mHealth SMS technology to improve healthcare

ATSC to provide software development services for NCI

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News